rs145474119

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_004924.6(ACTN4):​c.1998G>A​(p.Gln666Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00944 in 1,613,652 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0066 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0097 ( 110 hom. )

Consequence

ACTN4
NM_004924.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 6.91

Publications

1 publications found
Variant links:
Genes affected
ACTN4 (HGNC:166): (actinin alpha 4) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes. Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008]
ACTN4 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 19-38724553-G-A is Benign according to our data. Variant chr19-38724553-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00658 (1002/152378) while in subpopulation NFE AF = 0.0111 (756/68044). AF 95% confidence interval is 0.0105. There are 8 homozygotes in GnomAd4. There are 467 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1002 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTN4NM_004924.6 linkc.1998G>A p.Gln666Gln synonymous_variant Exon 16 of 21 ENST00000252699.7 NP_004915.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTN4ENST00000252699.7 linkc.1998G>A p.Gln666Gln synonymous_variant Exon 16 of 21 1 NM_004924.6 ENSP00000252699.2

Frequencies

GnomAD3 genomes
AF:
0.00659
AC:
1004
AN:
152260
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00195
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00911
Gnomad FIN
AF:
0.00668
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00842
AC:
2106
AN:
250048
AF XY:
0.00872
show subpopulations
Gnomad AFR exome
AF:
0.00204
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00795
Gnomad NFE exome
AF:
0.0136
Gnomad OTH exome
AF:
0.00588
GnomAD4 exome
AF:
0.00974
AC:
14234
AN:
1461274
Hom.:
110
Cov.:
36
AF XY:
0.00971
AC XY:
7057
AN XY:
726952
show subpopulations
African (AFR)
AF:
0.00173
AC:
58
AN:
33470
American (AMR)
AF:
0.00132
AC:
59
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
50
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00879
AC:
758
AN:
86250
European-Finnish (FIN)
AF:
0.00847
AC:
448
AN:
52922
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5766
European-Non Finnish (NFE)
AF:
0.0112
AC:
12439
AN:
1111940
Other (OTH)
AF:
0.00686
AC:
414
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1053
2106
3158
4211
5264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00658
AC:
1002
AN:
152378
Hom.:
8
Cov.:
32
AF XY:
0.00627
AC XY:
467
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41592
American (AMR)
AF:
0.00229
AC:
35
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00870
AC:
42
AN:
4828
European-Finnish (FIN)
AF:
0.00668
AC:
71
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
756
AN:
68044
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00760
Hom.:
2
Bravo
AF:
0.00584
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00894
EpiControl
AF:
0.00895

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACTN4: BP4, BP7, BS1, BS2 -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis Benign:1
Dec 15, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.7
DANN
Benign
0.74
PhyloP100
6.9
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145474119; hg19: chr19-39215193; API